English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Despite the advancement in diagnostic and treatment approach, cancer still remains as the leading cause of deaths worldwide. Due to the heterogeneity of tumours, many targeted therapies and personalised medicine have become ineffective. Recently, researchers have been working on the discovery and development of “dirty drugs” which simultaneously target several key pathways and mechanisms to kill cancerous cells. The cancer hallmarks, which consist of 10 characteristics of cancer development, have become the guideline to investigate the potential of bioactive compounds to be a “dirty drug”. As a locally-grown crops,  Carica papaya  has been explored extensively for their pharmacological activities including anti-cancer properties. This review provides an insight to the development of papaya extracts or their bioactive compounds as a potential broad-spectrum therapy for cancer by referring the mechanisms of actions against cancer hallmarks.

Anticancer Potential of Carica papaya through Modulation of Cancer Hallmarks